T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARXS
601
Arxis Inc
ARXS
$21B
| $143M | 0.01% |
+3,105,360
| New | +$121M |
|
602
Sterling Infrastructure
STRL
$15.3B
| $143M | 0.01% |
170,589
-240,138
| -58% | -$169M |
|
603
Amkor Technology
AMKR
$12.9B
| $143M | 0.01% |
1,659,478
+913,054
| +122% | +$65.1M |
|
604
Skyward Specialty Insurance
SKWD
$2.4B
| $142M | 0.01% |
2,440,678
+705,580
| +41% | +$33.3M |
|
605
East-West Bancorp
EWBC
$17.4B
| $141M | 0.01% |
1,093,452
-1,228,355
| -53% | -$151M |
|
606
Zurn Elkay Water Solutions
ZWS
$7.73B
| $139M | 0.01% |
2,756,245
-159,842
| -5% | -$7.82M |
|
607
Disc Medicine
IRON
$2.48B
| $137M | 0.01% |
1,875,399
+326,049
| +21% | +$22.4M |
|
608
Veeco
VECO
$2.9B
| $137M | 0.01% |
1,803,898
+1,681,753
| +1,377% | +$95.9M |
|
609
UL Solutions
ULS
$13.4B
| $136M | 0.01% |
1,338,282
-309,258
| -19% | -$29.2M |
|
610
Horace Mann Educators
HMN
$1.84B
| $136M | 0.01% |
2,638,462
+74,588
| +3% | +$3.46M |
|
611
American Healthcare REIT
AHR
$11.3B
| $136M | 0.01% |
2,606,778
+1,220,473
| +88% | +$60M |
|
612
Floor & Decor
FND
$4.97B
| $135M | 0.01% |
2,274,267
+103,634
| +5% | +$5.25M |
|
613
Agilent Technologies
A
$48.9B
| $135M | 0.01% |
1,014,750
+601,735
| +146% | +$73.3M |
|
614
PTC
PTC
$14.9B
| $133M | 0.01% |
1,168,473
-1,953,711
| -63% | -$264M |
|
615
TC Energy
TRP
$61.1B
| $132M | 0.01% |
1,993,589
-25,009
| -1% | -$1.65M |
|
616
United Therapeutics
UTHR
$20.6B
| $132M | 0.01% |
243,444
-162,003
| -40% | -$91.2M |
|
617
Nurix Therapeutics
NRIX
$2.36B
| $132M | 0.01% |
5,436,587
+2,146,354
| +65% | +$36.6M |
|
618
Casey's General Stores
CASY
$22.7B
| $132M | 0.01% |
165,653
+60,859
| +58% | +$49M |
|
619
Establishment Labs
ESTA
$1.95B
| $132M | 0.01% |
+1,533,497
| New | +$110M |
|
620
Ryman Hospitality Properties
RHP
$8.43B
| $131M | 0.01% |
1,022,663
+646,106
| +172% | +$71.7M |
|
621
Albemarle
ALB
$12.8B
| $131M | 0.01% |
973,486
+702,485
| +259% | +$124M |
|
622
General Dynamics
GD
$91.1B
| $131M | 0.01% |
370,547
+5,001
| +1% | +$1.71M |
|
623
Interactive Brokers
IBKR
$39.5B
| $131M | 0.01% |
1,504,030
+414,286
| +38% | +$34.5M |
|
624
First Bancorp
FBP
$4.11B
| $130M | 0.01% |
5,003,198
+1,209,827
| +32% | +$29.1M |
|
625
CMS Energy
CMS
$19.7B
| $129M | 0.01% |
1,688,159
-907,816
| -35% | -$68M |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.